Adropin
Energy Homeostasis-Associated Protein
76 Amino Acids · MW: Approximately 8,000 Da
Amino Acids
76
Molecular Weight
Approximately 8,000 Da
Half-life
Minutes to hours; not well defined
Research Score
4.3
Studies
95
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Adropin?
Adropin is a liver- and brain-derived peptide involved in energy homeostasis, lipid metabolism, and insulin sensitivity. In obesity research, lower adropin signaling is often associated with worse metabolic flexibility and higher adiposity.
Key Benefits & Mechanisms
energy metabolism support
fat oxidation signaling
insulin sensitivity modulation
metabolic flexibility
Research Summary
Adropin has been studied in rodent models of diet-induced obesity and in human observational cohorts linking circulating levels to metabolic syndrome. Mechanistic work suggests it can influence fatty-acid oxidation, glucose handling, and appetite-related neuroendocrine pathways.
Related Peptides
Oxyntomodulin
Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.
Weight ManagementCotadutide
MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Cotadutide is a synthetic oxyntomodulin analogue designed to engage both GLP-1 and glucagon receptors. It was developed to improve weight loss and metabolic markers in obesity and type 2 diabetes research.
Weight ManagementMazdutide
IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist
Mazdutide is a long-acting oxyntomodulin-inspired dual agonist being developed for obesity and metabolic disease. It is designed to drive clinically meaningful weight loss while improving glucose and lipid parameters.
Weight ManagementDulaglutide
Recombinant GLP-1 receptor agonist Fc fusion protein
Dulaglutide is a long-acting GLP-1 receptor agonist used primarily in type 2 diabetes. It consistently produces modest weight loss and is widely studied as a benchmark incretin mimetic.
Weight Management